(See all Stephen Jennings's publications in PubMed.)
"Modeling the pathology, immune responses, and kinetics of HSV-1 replication in the lip scarification model"
Egan KP, Allen AG, Wigdahl B, and Jennings SR
Virology, 15; 514: 124-133, 2018
"Animal models of herpes simplex virus immunity and pathogenesis"”
Kollias CM, Huneke RB, Wigdahl B, and Jennings SR
Journal of Neurovirology, 21: 8-23, 2015
"Immunological control of herpes simplex virus infections"”
Egan KP, Wu S, Wigdahl B, and Jennings SR
Journal of Neurovirology, 19: 328-45, 2013
"CD4+ T cells are required for priming of CD8+ T cells following infection with herpes simplex virus type -1"
Rajasagi NK, Kassim SH, Zhao X, Chervenak R, and Jennings SR
Journal of Virology, 83: 5256-5268, 2009
"Dendritic cells are required for optimal activation of natural killer functions following primary infection with herpes simplex virus type-1 (HSV-1)"
Kassim SH, Rajasagi NK, Ritz B, Pruett SB, Chervenak R, and Jennings SR
Journal of Virology, 83: 3175-3186, 2009
"Memory CD8+ T cells require CD28 costimulation"
Borowski AB, Boesteanu AC, Mueller YM, Carafides C, Topham DJ, Altman JD, Jennings SR, and Katsikis PD
The Journal of Immunology, 179(10): 6494-6503, 2007
"Modulation of dendritic cell maturation and functions by the Tax protein of human T cell leukemia virus type 1: implications for viral neuropathogenesis"
Jain P, Ahuja J, Khan ZK, Shimzu S, Meucci O, Kampani K, Jennings SR, and Wighdahl B
Journal of Leukocyte Biology, 82: 44-56, 2007
"In vivo ablation of CD11c-positive dendritic cells increases susceptibility to HSV-1 infection and hampers the NK and T cell responses"
Kassim SH, Rajasagi NK, Zhao X, Chervenak R, and Jennings SR
Journal of Virology, 80: 3985-3993, 2006
"Cytokine Profiles and Long Term Virus-Specific Antibodies following Immunization of CBA Mice with Equine Herpesvirus 1 and Viral Glycoprotein D"
Zhang Y, Smith PM, Frampton AR, Osterrieder N, Jennings SR, and O'Callaghan DJ
Viral Immunology, 16: 307-320, 2003
"Interferon-gamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function"
Oshima T, Laroux FS, Coe LL, Morise Z, Kawachi S, Bauer P, Grisham MB, Specian RD, Carter P, Jennings SR, "Granger DN, Joh T, and Alexander JS
Microvascular Research, 61: 130-143, 2000
"Expression of endothelial cell adhesion molecules in neovascularized tissue"
Vallien G, Langley R, Jennings SR, Specian R, and Granger DN
Microcirculation, 7: 249-258, 2000
"Severe immunopathology in the murine lung elicited by the pathogenic EHV-1 strain RacL11 correlates with the early production of MIP-1a, MIP-1b, MIP-2 and TNF-a"
Smith PM, Zhang YF, Grafton WD, Jennings SR, and O'Callaghan DJ
Journal of Virology, 74: 10034-10040, 2000
"Cytokine and adhesion molecule expression in SCID mice reconstituted with CD4+ T cells"
Kawachi S, Morise Z, Jennings SR, Conner E, Cockrell A, Laroux FS, Chervenak R, Wolcott M, van der Heyde H, Gray L, Feng L, Granger N, Specian RD, and Grisham MB
Inflammatory Bowel Disease, 6: 171-180, 2000
"Expression of intracellular interferon-g in HSV-1-specific CD8-positive T cells identifies distinct responding subpopulations during the primary response to infection"
Andersen H, Dempsey D, Chervenak R, and Jennings SR
The Journal of Immunology, 165: 2101-2107, 2000
"Determination of specific antibody-secreting cells following immunization with EHV-1 KyA and recombinant glycoprotein D by ELISPOT in CBA mice"
Zhang YF, Smith PM, Jennings SR, and O'Callaghan DJ
Virology, 268: 482-492, 2000
"Diminished secondary CTL response in draining lymph nodes on cutaneous challenge with herpes simplex virus"
Jones CM, Cose SC, McNally JM, Jennings SR, Heath WR, and Carbone FR
Journal of General Virology, 81: 407-414, 2000
"Phenotypic characteristics associated with the acquisition of HSV-specific CD8 T-lymphocyte-mediated cytolytic function in vitro"
McNally JM, Andersen HA, Chervenak R, and Jennings SR
Cellular Immunology, 194: 103-111, 1999
"Phenotypic identification of antigen-dependent and antigen-independent CD8 CTL precursors in the draining lymph node during acute cutaneous herpes simplex virus type 1 infection"
McNally JM, Dempsey D, Wolcott RM, Chervenak R, and Jennings SR
The Journal of Immunology, 163: 675-681, 1999